Hospitalization for heart failure among Medicare patients has declined substantially
October 18, 2011 in Cardiology
Between 1998 and 2008, heart-failure related hospitalizations declined substantially among Medicare patients, but at a lower rate for black men, according to a study in the October 19 issue of JAMA. Also, 1-year mortality rates declined slightly during this period, but remain high.
"Heart failure (HF) imposes one of the highest disease burdens of any medical condition in the United States with an estimated 5.8 million patients experiencing HF in 2006. The risk of developing HF increases with advancing age, and as a result, HF ranks as the most frequent cause of hospitalization and rehospitalization among older Americans. Heart failure is also one of the most resource-intensive conditions with direct and indirect costs in the United States estimated at $39.2 billion in 2010," according to background information in the article. "It is not known whether recent declines in ischemic heart disease and its risk factors have been accompanied by declines in HF hospitalization and mortality."
Jersey Chen, M.D., M.P.H., of the Yale University School of Medicine, New Haven, Conn., and colleagues conducted a study that included data of 55,097,390 fee-for-service Medicare beneficiaries hospitalized between 1998 and 2008 with a principal discharge diagnosis code for HF to identify trends in the HF hospitalization rate and 1-year mortality after HF hospitalization. The patients were from acute care hospitals in the United States and Puerto Rico. The average age of HF patients increased from 79.0 years to 79.9 years over the study period. There was a decrease in the proportion of female patients (58.9 percent to 55.7 percent) and increase in the proportion of black patients (11.3 percent to 11.7 percent).
An analysis of the data indicated that there was a relative decline of 29.5 percent of the overall risk-adjusted HF hospitalization rate from 1998 to 2008. Age-adjusted HF hospitalization rates declined over the study period for all race-sex categories, with black men having the lowest rate of decline.
Risk-standardized HF hospitalization rates in 1998 and 2008 varied significantly by state. The decline in this rate was significantly higher than the change in the national rate in 16 states and significantly lower in 3 states (Wyoming, Rhode Island, and Connecticut).
The researchers also found that risk-adjusted 1-year mortality decreased from 31.7 percent to 29.6 percent between 1999 and 2008, a relative decline of 6.6 percent, with substantial variation by state. There were 4 states with a statistically significant decline in 1-year risk-standardized mortality between 1998 and 2008 and 5 states with a statistically significant increase.
The authors add that because of the substantial decline in HF hospitalizations, compared to the rate of 1998, there were an estimated 229,000 HF hospitalizations that did not occur in 2008. "With a mean HF hospitalization cost of $18,000 in 2008, this decline represents a savings of $4.1 billion in fee-for-service Medicare."
The authors conclude that the overall decline in HF hospitalization rate was principally due to fewer individual patients being hospitalized with HF rather than a reduction in the frequency of HF hospitalizations. Also, the substantial geographic variation in HF hospitalization and 1-year mortality rates represent marked differences in outcomes that are not explained by insurance status.
More information: JAMA. 2011;306[15]:1669-1678.
Provided by
JAMA and Archives Journals
-
Heart failure linked to cognitive impairment
Feb 05, 2009 |
not rated yet |
0
-
ESC pilot registry in heart failure reflects improvement in chronic disease
Aug 30, 2011 |
not rated yet |
0
-
The effect of eplerenone vs. placebo on cardiovascular mortality
Aug 29, 2011 |
not rated yet |
0
-
For heart failure patients, risk of in-hospital death has decreased; readmission rate has increased
Jun 01, 2010 |
not rated yet |
0
-
Comparison of medications for heart failure finds difference in risk of death
Jan 11, 2011 |
not rated yet |
0
-
Motion perception revisited: High Phi effect challenges established motion perception assumptions
Apr 23, 2013 |
3 / 5 (2) |
2
-
Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update)
Apr 02, 2013 |
4.5 / 5 (11) |
5
-
The visual system as economist: Neural resource allocation in visual adaptation
Mar 30, 2013 |
5 / 5 (2) |
9
-
Separate lives: Neuronal and organismal lifespans decoupled
Mar 27, 2013 |
4.9 / 5 (8) |
0
-
Sizing things up: The evolutionary neurobiology of scale invariance
Feb 28, 2013 |
4.8 / 5 (10) |
14
-
Differences of Classical Mechanics when learned with Calc vs algebra?
1 hour ago
-
what is the distance traveled
5 hours ago
-
Image of a Convex Lens Cut in Half Horizontally
8 hours ago
-
Ray tracing throught optical system of thick lenses
9 hours ago
-
Faraday's law on circular wire
9 hours ago
-
Specific Exergy vs Specific Flow Exergy
11 hours ago
- More from Physics Forums - Classical Physics
More news stories
Costs to treat stroke in America may double by 2030
Costs to treat stroke are projected to more than double and the number of people having strokes may increase 20 percent by 2030, according to the American Heart Association/American Stroke Association.
Cardiology
5 hours ago |
not rated yet |
0
New blood-thinner measures may cut medication errors
Blood thinners are the preferred treatment option to prevent heart attacks, blood clots and stroke, but they are not without risk, and not just because of their side effects. These high-risk drugs, known as anticoagulants, ...
Cardiology
8 hours ago |
not rated yet |
0
Registry questions superiority of bivalirudin over heparin
Results from a large observational study reported at EuroPCR 2013 today question whether bivalirudin is superior to heparin in the absence of GPIIb/IIIa blockade, showing similar 30-day mortality in patients with non-ST segment ...
Cardiology
8 hours ago |
not rated yet |
0
Study shows low rate of late lumen loss with bioresorbable DESolve device
The DESolve bioresorbable coronary scaffold system achieves good efficacy and safety with low rates of late lumen loss and major coronary adverse events at six months, show first results from the pivotal DESolve Nx trial ...
Cardiology
8 hours ago |
not rated yet |
0
Biodegradable stent proves non-inferior to drug-eluting stent
The Orsiro stent, which is a novel stent platform eluting sirolimus from a biodegradable polymer, demonstrated non-inferiority to the Xience Prime everolimus-eluting stent for the primary angiographic endpoint of in-stent ...
Cardiology
May 21, 2013 |
5 / 5 (1) |
0
Systematic screening of med adherence will ID barriers
(HealthDay)—Implementation of systematic monitoring for medication adherence will allow for identification of barriers to adherence and tailoring of interventions, according to a viewpoint piece published ...
Baby's life saved with groundbreaking 3-D printed device that restored his breathing
Every day, their baby stopped breathing, his collapsed bronchus blocking the crucial flow of air to his lungs. April and Bryan Gionfriddo watched helplessly, just praying that somehow the dire predictions weren't true.
'Boys will be boys' in US, but not in Asia
A new study shows there is a gender gap when it comes to behavior and self-control in American young children – one that does not appear to exist in children in Asia.
Swine flu pandemic of 2009 more deadly for younger adults, study finds
As the world prepares for what may be the next pandemic strain of influenza virus, in the H7N9 bird flu, a new UC Irvine study reveals that the 2009 H1N1 swine flu pandemic was deadliest for people under the age of 65, while ...
American cancer society celebrates 100 years of progress
(HealthDay)—The American Cancer Society, which is celebrating on Wednesday a century of fighting a disease once viewed as a death sentence, is making a pledge to put itself out of business.
CT detects twice as many lung cancers as X-ray at initial screening exam
National Lung Screening Trial (NLST) investigators also conclude that the 20 percent reduction in lung cancer mortality with low-dose computed tomography (LDCT) versus chest X-ray (CXR) screening previously reported in the ...